Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Type 17 CD8+ T cells display enhanced antitumor immunity.

Type 17 CD8+ T cells display enhanced antitumor immunity. Blood. 2009 Jul 16; 114(3):596-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.